Stereotactic Ablative Radiotherapy Combined with Immune Checkpoint Inhibitors Reboots the Immune Response Assisted by Immunotherapy in Metastatic Lung Cancer: A Systematic Review

Background: Immune checkpoint inhibitors (ICI) have represented a revolution in the treatment of non-small-cell lung cancer (NSCLC). To improve these results, combined approaches are being tested. The addition of stereotactic ablative radiotherapy (SABR) to ICI seems promising. A systematic review w...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Mol Sci
Main Authors: Chicas-Sett, Rodolfo, Morales-Orue, Ignacio, Castilla-Martinez, Juan, Zafra-Martin, Juan, Kannemann, Andrea, Blanco, Jesus, Lloret, Marta, Lara, Pedro C
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2019
Assuntos:
Review
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6540197/
https://ncbi.nlm.nih.gov/pubmed/31052488
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20092173
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares